603367.SH
辰欣药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 13.61
−3.48%Margins
Gross margin
51.3%
EBITDA margin
20.7%
EBIT margin
14.3%
Net margin
12.1%
FCF margin
15.9%
6.5%
Return on equity
5.3%
Return on assets
7.6%
Return on invested capital
0.44x
Asset turnover
CNY 601.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026